Actively Recruiting
Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain Injury
Led by Shanghai 6th People's Hospital · Updated on 2026-04-23
90
Participants Needed
2
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cerebrocardiac syndrome (CCS), including myocardial injury, arrhythmia or heart failure is one of serious complications of traumatic brain injury (TBI), mostly occurs within seven days after TBI, which directly aggravates the brain damage and affects the prognosis of TBI patients. Accumulative evidences suggest that autonomic nervous system disorder is a key initiation point for CCS, but how TBI affects the specific action patterns is not yet clear. Therefore, elucidating the neural mechanisms of TBI-induced CCS, maintaining the central sympathetic-parasympathetic balance through novel interventions such as noninvasive brain stimulation, may fundamentally block the downstream peripheral mechanism, thus achieving effective prevention and treatment for CCS. Based on the current emerging research in brain connectomics and lesion-symptom mapping, we speculate that cerebral contusions can cause structural or functional disconnection of key nodes in the central autonomic nervous system regulatory network, thereby mediating the occurrence of TBI-induced CCS. In this study, magnetic resonance imaging (MRI) or functional MRI (fMRI) examinations were performed in patients with mild or moderate TBI with aim to explore the association between structural and functional disconnection caused by cerebral contusion and TBI-induced CCS, and to screen out the neural anatomical structures to predict CCS following TBI, providing therapy targets for prevention and treatment of CCS.
CONDITIONS
Official Title
Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with isolated closed head trauma
- Age 18-80 years old
- Admitted to hospital within 24 hours of injury
- Mild or moderate TBI (Glasgow Coma Scale score of 9-15)
- Signed consent form
You will not qualify if you...
- Severe TBI (Glasgow Coma Scale score of 3-8)
- History of stroke, TBI, intracranial tumor, or brain surgery in the past 1 year
- History of coronary heart disease, structural heart disease, or other primary heart diseases or suspected cardiac symptoms prior to injury
- Causes of abnormal cardiac biomarkers such as renal insufficiency, severe anemia, sepsis, or cardiotoxic drugs
- Not suitable for MRI exams, including pregnancy or metal implants
- Underwent surgery before MRI or cardiac tests
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Shanghai 6th People's Hospital
Shanghai, China, 200233
Actively Recruiting
2
Shanghai Sixth People's Hospital
Shanghai, China
Actively Recruiting
Research Team
H
Hao Chen, M.D., Ph.D.
CONTACT
L
Lai Wei, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here